FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfilePasithea Therapeutics Corp.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
KTTAW
Pasithea Therapeutics Corp. Stock AnalysisComprehensive stock analysis for Pasithea Therapeutics Corp. (KTTAW) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisKTTAW
KTTAW
Pasithea Therapeutics Corp.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
KTTAW
  1. Home
  2. Stocks
  3. Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp.

🇺🇸KTTAW•NASDAQ

Pasithea Therapeutics Corp.

🇺🇸KTTAW•NASDAQ
Market cap
$20.84K

Your view on KTTAW

Mkt Cap
$20.84K
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Pasithea Therapeutics Corp.

Industry
Biotechnology
Sector
Healthcare
CEO
Tiago Reis Marques
Headquarters
1111 Lincoln Road, Miami Beach, FL, US
Industry
Biotechnology
Sector
Healthcare
CEO
Tiago Reis Marques
Headquarters
1111 Lincoln Road, Miami Beach, FL, US
Description

Pasithea Therapeutics Corp. is a biotechnology firm dedicated to exploring and developing therapies for various psychiatric and neurological conditions. Beyond its research endeavors, the company intends to establish clinics specializing in the treatment of depression.

At these facilities, certified pharmacists will administer intravenous ketamine infusions, and the firm will also extend business support services for these operations. Founded in 2020, Pasithea Therapeutics Corp. maintains its corporate headquarters in Miami Beach, Florida.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Pasithea Therapeutics Corp.. Starting points for Pasithea Therapeutics Corp.: EPS -$440.92, beta 0.29 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Pasithea Therapeutics Corp.. Trailing twelve-month EPS for Pasithea Therapeutics Corp. stands at -$440.92. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Pasithea Therapeutics Corp.. Pasithea Therapeutics Corp. has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold KTTAW12 companies
More Biotechnology companies
TickerTypeCompanySectorExchangeMkt cap
BXPHFBotanix Pharmaceuticals LimitedHealthcareOTC$89.0M
ARUXFAcrux LimitedHealthcareOTC$1.8M
ARVNArvinas, Inc.HealthcareNASDAQ$423.0M
ARWRArrowhead Pharmaceuticals, Inc.HealthcareNASDAQ$5.8B
ASBPAspire Biopharma Holdings, Inc.HealthcareNASDAQ$822,602
ASBPWAspire Biopharma Holdings, Inc.HealthcareNASDAQ$121,920
ASCLFAscletis Pharma Inc.HealthcareOTC$2.1B
ASEP.CNAsep Medical Holdings IncHealthcareCNQ—
ASMBAssembly Biosciences, Inc.HealthcareNASDAQ$454.4M
ASNDAscendis Pharma A/SHealthcareNASDAQ$16.6B
ASPEAspen Neuroscience Inc.HealthcareNASDAQ$361.2M
ASPHFAscentage Pharma Group InternationalHealthcareOTC$3.2B
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold Pasithea Therapeutics Corp., and how their positions are changing. At a $20,838 market value, institutional positions materially move Pasithea Therapeutics Corp.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by Pasithea Therapeutics Corp. executives and directors. Shares of Pasithea Therapeutics Corp. have traded between $0.0021 and $0.01 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Pasithea Therapeutics Corp.. Coverage tracks Pasithea Therapeutics Corp. within Biotechnology (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Pasithea Therapeutics Corp.

KTTAW AnalysisFair
Past
1
Growth
2
Health
5
Profit
1
Value
1